Olon SpA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Olon SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10798
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Olon SpA (Olon), formerly Antibioticos SpA, a susbsidiary of P&R S.p.A. is a developer and producer of active pharmaceutical ingredients. The company offers products such as azacitidine, bezafibrate, ibuprofen sodium, acamprosate calcium, acebutolol hydrochloride, acitretin, thalidomide, abacavir sulfate, etretinate, doxorubicin hydrochloride, abiraterone acetate, rifampycin and pridinol mesylate, among others. Its products are used in the therapeutic areas such as muscle relaxant, antibacterial, anticholinergic, antibiotic, anti-parkinson, mucolitic, hepatoprotectant, diuretic, antiviral, antineoplastic, alcohol dependence treatment, bronchodilator, HIV proteinase inhibitor, anxiolytic, lipoprotein disorders and exclusive parenteral feeding. Olon also provides custom synthesis and contract manufacturing services. The company operates through its manufacturing facilities located in Italy and Spain. Olon is headquartered in Rodano, Italy.

Olon SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Olon SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Olon SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Olon SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Olon SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Olon SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Olon SpA, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Olon to Acquire API Manufacturing Facility from Novartis 10
Olon Acquires Chemical Division from Ricerca Biosciences 11
Private Equity 12
Main Market Partners Acquires Ricerca Biosciences 12
Asset Transactions 13
Olon Acquires Chemical Division from Ricerca Biosciences 13
WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 14
Salix Pharma Acquires Worldwide IP Rights To Amorphous Rifaximin From Olon 15
Eurofins Scientific Completes Acquisition Of Pan Labs Pharmacology Unit From Ricerca Biosciences 16
Acquisition 17
Frontage Laboratories Acquires Concord Biosciences 17
Olon to Acquire Infa Group 18
Olon SpA – Key Competitors 19
Olon SpA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Research And Development 20
Jan 26, 2018: Olon Announces Investment and Expansion of APIs Manufacturing Capabilities 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Olon SpA, Pharmaceuticals & Healthcare, Key Facts 2
Olon SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Olon SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Olon SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Olon SpA, Deals By Therapy Area, 2012 to YTD 2018 8
Olon SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Olon to Acquire API Manufacturing Facility from Novartis 10
Olon Acquires Chemical Division from Ricerca Biosciences 11
Main Market Partners Acquires Ricerca Biosciences 12
Olon Acquires Chemical Division from Ricerca Biosciences 13
WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 14
Salix Pharma Acquires Worldwide IP Rights To Amorphous Rifaximin From Olon 15
Eurofins Scientific Completes Acquisition Of Pan Labs Pharmacology Unit From Ricerca Biosciences 16
Frontage Laboratories Acquires Concord Biosciences 17
Olon to Acquire Infa Group 18
Olon SpA, Key Competitors 19
Olon SpA, Subsidiaries 19

List of Figures
Olon SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Olon SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Olon SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Olon SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Olon SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Olon SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Olon SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Olon SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Olon SpA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carrier Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Carrier Corporation Mergers and …
  • SEVERNAYA KAZNA Bank:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SEVERNAYA KAZNA Bank Mergers an …
  • Nutricia GmbH:企業の戦略的SWOT分析
    Nutricia GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • PATRIZIA Immobilien AG:企業のM&A・事業提携・投資動向
    PATRIZIA Immobilien AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PATRIZIA Immobilien AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Annaly Capital Management, Inc.:企業の戦略・SWOT・財務分析
    Annaly Capital Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Annaly Capital Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • WCT Engineering Berhad:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' WCT Engineering Berhad Mergers …
  • Ashok Leyland Limited:企業の戦略・SWOT・財務分析
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • VF Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' VF Corporation Mergers and Acqu …
  • Hachette Filipacchi Medias SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hachette Filipacchi Medias SA M …
  • Daily Mail & General Trust plc (DMGT):企業の財務・戦略的SWOT分析
    Daily Mail & General Trust plc (DMGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Durr AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Durr AG Mergers and Acquisition …
  • FAR Limited (FAR):企業の財務及び戦略的SWOT分析
    Summary FAR Limited (FAR) is an oil and gas exploration company that provides exploration, development, production and acquisition of oil and natural gas. The company has pre-appraisal and exploration assets in West and East Africa. It also holds area surrounded by petroleum systems in West Africa. …
  • Syndax Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Syndax Pharmaceuticals, Inc. Me …
  • Hitachi, Ltd. (6501):企業のM&A・提携動向(発電分野)
    Summary Hitachi, Ltd. (Hitachi) is a multinational company with operations in sectors such as engineering and electronics, nuclear, transportation and industrial systems. It manufactures and sells information and telecommunication systems, power systems, social infrastructure and industrial systems, …
  • SystemD Inc. (3804):企業概要、財務及び戦略的SWOT分析
    Summary SystemD Inc. (SDI) is an information technology company. The company develops and sells application software and solutions. It offers solutions such as gakuen solutions, public education solutions, public accounting solutions, wellness solutions and software engineering. SDI’s Gakuen solutio …
  • Metropolitan Bank and Trust Company:企業の戦略・SWOT・財務分析
    SummaryMetropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • The British United Provident Association Ltd:企業のM&A・提携動向(医療分野)
    Summary The British United Provident Association Ltd (Bupa) is a leading global healthcare group. It offers health insurance and other funding products, chronic disease management services, home healthcare services, workplace health services and care services, comprising residential and nursing home …
  • KfW Bankengruppe:企業のM&A・提携・投資分析
    KfW Bankengruppe - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KfW Bankengruppe Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • LifeAssays ABの企業概要及び財務/SWOT分析
    LifeAssays AB Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, LifeAssays AB annual and quarterly forecasts made by stock market experts. The report also enables direct compar …
  • Txcom S.A. (ALTXC):企業概要、財務及び戦略的SWOT分析
    Summary TXCOM S.A. (Txcom) is a software solution provider. The company designs, builds and markets rugged and innovative data capture solutions. It offers a wide range of bluetooth barcode scanners for the logistics and transportation markets. Txcom group’s activities include automatic, thermal and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆